Sphera Funds Management »

Pharvaris N V shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 245k 28.05

More positions owned by Sphera Funds Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Sanofi Sponsored Adr (SNY)
Cytokinetics Com New (CYTK)
NOVA MEASURING Instruments L (NVMI)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Tower Semiconductor Shs New (TSEM)
Nice Sponsored Adr (NICE)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Astrazeneca Sponsored Adr (AZN)
Biogen Idec (BIIB)
Bridgebio Pharma (BBIO)

View all positions for Sphera Funds Management

Top funds holding Pharvaris N V

venBio Partners
Viking Global Investors
VR Adviser
Cormorant Asset Management
EcoR1 Capital
T. Rowe Price Associates
Deerfield Management Company
Commodore Capital
5AM Venture Management
Sphera Funds Management
Soleus Capital Management
Millennium Management
Citadel Advisors
Blackstone Group
Walleye Trading Advisors

View all funds holding Pharvaris N V